In contrast, the molecular target of anti-IFNAR1 is a key element of innate and adaptive antiviral immunity, which suggests why anti-IFNAR1 therapy is associated with a higher risk for certain viral infections such as HZ. The gene discussed is IFNAR1; the disease is viral infectious disease.